Dewey H. Blocker
Plus aucun poste en cours
Provenance du réseau au premier degré de Dewey H. Blocker
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
18
| Subsidiary | Pharmaceuticals: Major | 18 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Dewey H. Blocker via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Pharmaceuticals: Major | Director/Board Member Human Resources Officer Chief Executive Officer Director of Finance/CFO Director of Finance/CFO Director/Board Member Director/Board Member Director/Board Member | |
| ALLERGAN, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
| University of California, Los Angeles | College/University | Graduate Degree Undergraduate Degree | |
| Keio University | College/University | Undergraduate Degree Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing General Counsel | |
| PDL BIOPHARMA, INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
Quark Pharmaceuticals, Inc.
 Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Washington Biotechnology & Biomedical Association | Chairman Director/Board Member | ||
SBI Investment Co., Ltd.
 SBI Investment Co., Ltd. Investment ManagersFinance SBI Investment Co., Ltd. (SBI Investment) is a venture capital subsidiary of SBI Holdings, Inc. (TK: 8473) headquartered in Tokyo, Japan. The firm was formed in 2005 through the merger of SBI Ventures K.K., Softbank Contents Partners Corp. and Biovision Capital Corp. | Investment Managers | Chief Executive Officer Director/Board Member | |
| OBSEVA SA | Pharmaceuticals: Major | Chief Executive Officer | |
| The HENLEY College | College/University | Masters Business Admin | |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Aquavit Pharmaceuticals, Inc.
 Aquavit Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquavit Pharmaceuticals, Inc. operates as a healthcare company that discovers, develops, and commercializes therapeutic products. It offers pharmaceuticals, nutraceuticals, and biologics. The company was founded in October 2010 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
Century Club of San Diego
 Century Club of San Diego Miscellaneous Commercial ServicesCommercial Services Century Club of San Diego engages in the promotion of golf events to support San Diego community and local youth programs. The company was founded in July 1961 and is headquartered in La Jolla, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Petra Pharma Corp.
 Petra Pharma Corp. Pharmaceuticals: MajorHealth Technology Petra Pharma Corp. operates as a drug development company that develops novel small molecules for the treatment of cancer and metabolic diseases. The company was founded by Lewis Clayton Cantley and Nathanael S. Gray in 2016 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
| INDAPTUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Decoy Biosystems, Inc.
 Decoy Biosystems, Inc. BiotechnologyHealth Technology Decoy Biosystems, Inc. provides cancer immunotherapy services. The company was founded on August 14, 2013 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
Biopartners GmbH
 Biopartners GmbH Pharmaceuticals: MajorHealth Technology Biopartners GmbH engages in the development of biopharmaceutical products in the fields of endocrinology, multiple sclerosis, and virology. The company was founded in 2000 and is headquartered in Baar, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Sonrgy, Inc. | Chief Executive Officer | ||
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BOLT BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Deep Genomics, Inc.
 Deep Genomics, Inc. BiotechnologyHealth Technology Deep Genomics, Inc. provides machine learning, genome biology and precision medicine. It develops an integrated computational system that could learn, predict, and interpret how genetic variation, whether natural or therapeutic, alters crucial cellular processes. The firm offers SPIDEX database, which is a set of genetic variants and their predicted effects on human splicing across the entire genome. Its SPIDEX database covers all synonymous, missense, and nonsense exonic SNVs, as well as intronic SNVs that are up to 300nt from splice junctions. The company was founded by Brendan Frey and Hui Yuan Xiong in 2015 and is headquartered in Toronto, Canada. | Biotechnology | Chief Executive Officer | |
Mylan Specialty LP
 Mylan Specialty LP Pharmaceuticals: MajorHealth Technology Mylan Specialty LP develops, manufactures, and markets respiratory disease & allergy treatment products. The company was founded in 1978 and is headquartered in Morgantown, WV. | Pharmaceuticals: Major | Compliance Officer | |
| Society of Human Resource Management | Corporate Officer/Principal | ||
| COVANCE INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Pulmatrix Operating Co., Inc.
 Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Pulmatrix Operating Co., Inc. develops pharmaceutical products for respiratory infectious diseases. Its iSPERSE powders can be used with an array of dry powder inhaler technologies and can be formulated with virtually any drug substance. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov and Robert S. Langer in 2003 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Akron
 University of Akron Other Consumer ServicesConsumer Services University of Akron provides public research education. Its programs include under graduate studies, graduate studies, international studies, law, and continuing education. The company was founded in 1870 and is headquartered in Akron, OH. | College/University | Graduate Degree | |
| University of Oklahoma | College/University | Masters Business Admin | |
| LADRX CORPORATION | Biotechnology | Corporate Officer/Principal | |
Azelon Pharmaceuticals, Inc.
 Azelon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azelon Pharmaceuticals, Inc. develops biopharmaceutical drugs for the treatment of osteoporosis. It develops parathyroid hormone analogs for the treatment of bone diseases, which are characterized by deficits in bone formation, including osteoporosis, orthopedic conditions and renal bone disease. The company was founded by Paul Morley and Godfrey Marchand in 2000 and is headquartered in West Conshohocken, PA. | Pharmaceuticals: Major | President | |
| SORRENTO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Semnur Pharmaceuticals, Inc.
 Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
SCILEX Pharmaceuticals, Inc.
 SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Pharmaceuticals: Major | Chief Executive Officer | |
Celularity, Inc. (United States)
 Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | Miscellaneous Commercial Services | Director/Board Member | |
Scilex, Inc.
 Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
| SCILEX HOLDING COMPANY | Pharmaceuticals: Other | Chief Executive Officer | |
Calibra Medical LLC
 Calibra Medical LLC Medical SpecialtiesHealth Technology Calibra Medical LLC develops and markets medical devices and technologies in the diabetes sector. Its products include finesse and insulin delivery devices. The company was founded by Daniel Hawkins and Clifton A. Alferness in 2004 and is headquartered in Wayne, PA. | Medical Specialties | Human Resources Officer | |
| The Northwest Compensation & Rewards Forum | Corporate Officer/Principal | ||
| HR Executive Forum | Corporate Officer/Principal | ||
| Golden Gate University | College/University | Graduate Degree | |
| University of California, Santa Barbara | College/University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 42 |
| Japon | 4 |
| Suisse | 3 |
| Royaume-Uni | 2 |
| Israël | 2 |
Sectorielle
| Health Technology | 35 |
| Consumer Services | 8 |
| Commercial Services | 4 |
| Finance | 2 |
Opérationnelle
| Director/Board Member | 88 |
| Corporate Officer/Principal | 34 |
| President | 30 |
| Chief Executive Officer | 26 |
| Director of Finance/CFO | 23 |
Relations les plus connectées
| Insiders | |
|---|---|
| Yoshitaka Kitao | 49 |
| Brian O'Callaghan | 20 |
| Jaisim Shah | 17 |
| John E. Gebhart | 16 |
| Shintaro Asako | 15 |
| Michael T. Schutzler | 11 |
| David Lowrance | 10 |
| Glen Y. Sato | 10 |
| Edward Danse | 9 |
| Robert Takeuchi | 8 |
| Michelle Carpenter | 8 |
| Takaaki Tobaru | 8 |
| Hien DeYoung | 8 |
| Shiro Mita | 6 |
| Steven C. Tarr | 6 |
- Bourse
- Insiders
- Dewey H. Blocker
- Connexions Sociétés
